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Abstract: A new class of solid supported chiral imidazolidinones organocatalysts for the catalytic 
reduction of imines with trichlorosilane was developed. Polystyrene proved to be a more effective 
support than silica in terms of both chemical and stereochemical efficiency. Even with a loading as 
low as 1 mol % the best performing supported catalyst showed a remarkable activity and 
stereocontrol ability, promoting the reduction with stereoselectivities reaching 98% e.e. and in most 
cases ranging between 90-95% e.e. The general scope of the methodology and the good recyclability 
of the immobilized catalyst were demonstrated. The polystyrene-anchored chiral catalyst was also 
used to prepare packed bed reactors for the continuous flow synthesis of chiral amines, that were 
obtained in excellent yields and enantioselectivities. By exploiting the chiral organocatalytic reactor, 
the in-flow stereoselective synthesis of a common, immediate precursor of rivastigmine, of the 
calciomimetic (R)-NPS 568 and of Acrylamide (S)-A, currently under study for the treatment of 
neuropathic pain, was successfully accomplished. 
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Chiral amines are very important pharmacophore that can be found in several biologically active 
molecules and agrochemical compounds. The reduction of ketomines either by metal-catalyzed 
hydrogenation[1] or by organocatalytic methodologies[2] is a very convenient strategy to access to this 
class of molecules. Among the available catalytic methods, the stereoselective reduction of imines 
with trichlorosilane (HSiCl3) promoted by chiral Lewis bases has been investigated by several 
research groups and has proved to be very efficient.[3] The possibility to use in a catalytic continuous 
flow process a very cheap, readily available and atoxic reagent like HSiCl3 is extremely attractive, in 
view of a large scale preparation of enantiopure amines of industrial interest.[4] The immobilization 
of the chiral catalyst would allow not only to recycle the heterogenized chiral catalytic species in the 
in-batch reaction,[5] but also to assembly a catalytic reactor to be employed in the enantioselective 
reduction under continuous flow conditions [6] with the catalyst permanently residing in the reactor.  
We have recently reported a new class of highly active chiral Lewis bases, able to promote the 
reduction of a wide variety of imines with low catalyst loading (down to 0.1% mol), occurring in 
quantitative yields and enantioselectivities usually higher than 90% (Figure 1, catalyst type I).[7]  
Here we report the immobilization of this new class of imidazolidinone-based picolinamides and 
their use in the enantioselective C=N bonds reduction; despite it was often observed that the 
heterogenization of chiral catalysts led to a decreased catalytic efficiency, in the present study the 
polymer-support Lewis base of choice showed a remarkable behavior, even at 1 mol % loading, 
promoting the reaction in high yields and stereoselectivities up to 98 % e.e.. Not only the 
recyclability was demonstrated under batch conditions, but, for the first time, a chiral organocatalytic 
reactor for the enantioselective, trichlorosilane-mediated imine reduction under continuous flow 
conditions was successfully prepared and employed for the in-flow synthesis of chiral amines, 
including advanced intermediates of pharmaceutically relevant compounds.[8] 
For the preparation of the supported picolinamide, we started from (L)-Tyrosine to build up the 
chiral scaffold and exploited the phenolic residue as site to anchor the catalyst onto a solid support 
(Figure 1, catalyst type II).  
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Figure 1. General synthetic strategy for the preparation of solid supported picolinamides. 
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The synthesis of silica supported picolinamide involved the preparation of O-allyl protected 
picolinamide 2 starting from the known intermediate 1 (Scheme 1).[9] Compound 2 was then 
converted into the corresponding trimethoxysilyl derivative 3, that was grafted onto commercially 
available SiO2 (Apex Prepsil Silica Media 8 µm) to afford the silica-supported catalyst S1 (loading: 
0.25 mmol/g, as determined by weight difference). 
 
Scheme 1. Synthesis of silica supported catalyst S1. 
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Another silica supported picolinamide, featuring a longer linker between the catalyst's active site 
and the solid support, was also synthesized (Scheme 2). Starting from imidazolidinone 4,[10] a click 
reaction with 1-(allyloxy)-4-(azidomethyl)benzene gave compound 5 that was then converted into 
the corresponding picolinamide 6. Platinum catalyzed hydrosilylation with HSi(OMe)3 followed by 
grafting onto commercially available SiO2(Apex Prepsil Silica Media 8 µm) afforded the 
immobilized catalyst S2 (load = 0.3 mmol/g). 
 
Scheme 2. Synthesis of silica supported catalyst S2. 
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The synthetic strategy for the preparation of the polymer supported catalyst takes advantage of the 
known imidazolidinone 8[10] featuring a styrene moiety to be employed in the polymerization step of 
the synthesis. Intermediate 8 was converted into the corresponding picolinamide 9 by reaction with 
picolinic acid and ethylchloroformate in the presence of N-methyl morpholine as a base. Monomer 9 
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was then polymerized by AIBN-promoted radical copolymerization with divinylbenzene as co-
monomer, in the presence of toluene and 1-dodecanol as porogens (Scheme 3). The loading of P1 
was evaluated to be 0.57 mmol/g, based on the stoichiometry of polymerization reaction. 
 
Scheme 3. Synthesis of polymer supported catalyst P1. 
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The trichlorosilane-mediated reduction of imines N-phenyl 10a and N-PMP (p-methoxyphenyl) 
protected 10b derived from acetophenone was chosen as model reaction to test the solid supported 
catalysts (Table 1).  
Catalyst S1 promoted the reduction of both substrates in excellent yields and very good 
enantioselectivities (entries 1 and 2). The presence of a longer linker as in catalyst S2 did not 
improve the chemical efficiency, but had a detrimental effect on the stereoselectivity, that was 
markedly reduced (entries 3 and 4). Polystyrene supported picolinamide P1 proved to be the best 
catalytic system, affording the desired products (11a and 11b) in very good yields and excellent 
stereoselectivities (97% e.e., entries 5 and 6). 
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Table 1. Catalyst screening. 
N HN
HSiCl3
Cat
 
(20
 mol%)
CH2Cl2
RT,
 
18
 
h
PG PG
10 11
10a: PG=Ph
10b: PG=PMP  
Entrya Catalyst PG Yield (%)b ee (%)c 
1 S1 Ph 97 82 
2 S1 PMP 98 86 
3 S2 Ph 70 21 
4 S2 PMP 95 75 
5 P1 Ph 92 97 
6 P1 PMP 94 97 
a) Reaction conditions: imine (0.1 mmol), HSiCl3 (0.5 mmol), DCM(1 mL). b) Isolated yield after 
chromatography. c) Enantiomeric excess was determined by HPLC on chiral stationary phase; the absolute 
configuration was confirmed by comparison with literature data, see ref. 7. 
 
On the basis of these preliminary investigations, P1 was selected for further studies (Table 2).  
 
Table 2. Screening of catalyst loading. 
N HN
HSiCl3
P1
 
(20
 mol%)
CH2Cl2
RT,
 
18
 
h
PMP PMP
11b10b  
Entrya P1 (mol%) Yield (%)b ee (%)c 
1 20 94 97 
2 10 94 96 
3 5 92 95 
4 5d 82 94 
5 1 96 95 
6 1d 46 93 
a) Reaction conditions: imine (0.1 mmol), HSiCl3 (0.5 mmol), DCM(1 mL). b) Isolated yield after 
chromatography. c) Enantiomeric excess was determined by HPLC on chiral stationary phase. d) Reaction 
time: 4h. 
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Remarkably, the amount of the supported catalyst could be reduced to just 1 mol%, without an 
appreciable loss of the chemical or stereochemical activity (Table 2, entry 1 vs entry 5). When 
reaction time was reduced to 4 hours, a loading of 5 mol% of P1 was sufficient to afford chiral amine 
11b in 82% yield and 94% e.e., thus confirming the excellent chemical behavior of the heterogenized 
chiral Lewis  base. 
The general scope of the reaction was then studied. Different C-aryl substituted imines were 
reacted with HSiCl3 in the presence of polymer-supported catalyst P1 (Scheme 4). 
 
Scheme 4. Reaction scope. 
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Substrates bearing both electron withdrawing (11e-11i) and electron donating groups (11c, 11d, and 
11j) were reduced in very good yields and excellent e.e., up to 97%. Notably, amine 11k, a direct 
precursor of rivastigmine (see below, Figure 2), was obtained in 80% yield and 95% e.e.. In all cases, 
the supported catalyst showed to behave like the non-immobilized catalyst under homogeneous 
conditions, and afforded the products with the (R) absolute configuration, thus suggesting that 
polymer-supported P1 promotes the reduction according to the same mechanism proposed for the 
homogeneous catalyst. [7] 
The α-amino ester 11m was obtained in 96% yield and only 65% e.e., β−amino esters 11n, 11o and 
11p, precursors of chiral β−lactams, were isolated in quantitative yields and good e.e., up to 84%. 
In order to demonstrate the practical applicability of the heterogeneous catalyst P1, both its 
recovery and recycle were studied in the reduction of imine 10k, a key common intermediate for the 
preparation of several, pharmaceutically relevant molecules (Figure 2).  
 
Figure 2. Some biologically active chiral amines featuring 3-alcoxyaryl residue. 
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With a two hours reaction time for each cycle, the same immobilized catalyst could be used for 
seven reaction cycles, affording a constant yield, typically ranging between 80 and 85%, and a 
reproducible, high level of enantioselectivity, of about 94% e.e. (Table 3).[11] 
 
Table 3. Recycling experiments. 
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HSiCl3
 
P1 20
 mol%
CH2Cl2
RT,
 
2
 
h
HN
PMP
BnO
N
PMP
BnO
11k10k  
Cyclea Yield (%)b ee (%)c 
1st 80 94 
2nd 81 94 
3rd 80 94 
4th 79 93 
5th 87 93 
6th 84 90 
7th 76 87 
a) Reaction time of each cycle: 2 hours. b) Isolated yield. c) E.e. was determined by HPLC on chiral stationary phase 
 
Polystyrene supported catalyst P1 was then employed for the fabrication of packed bed reactors, 
required for developing an efficient and convenient continuous flow reduction of imines with HSiCl3. 
P1 (0.3 g) was packed into a stainless-steel HPLC column (l: 6 cm, id: 0.4 cm, V: 0.75 mL). A 0.05 
M solution of 10b and HSiCl3 in CH2Cl2 was pumped into the reactor through a syringe pump at 0.4 
mL/h (res time: 30 min) at room temperature. The outcome of the reactor was collected into a flask 
containing NaOH 10% solution and the product isolated by extraction and solvent evaporation. After 
the first two operating hours, the product was collected at 1 h intervals and analyzed in order to 
determine the conversion and the ee. Results of the continuous flow experiments are reported in 
Table 4. 
 
Table 4. Continuous flow synthesis of amine 11b. 
HN
PMP
HSiCl3
CH2Cl2
P1
Packed-bed
reactor
11b
N
PMP
NaOH
H2O
10b
 
Entry Running time (min) Yield (%)
a ee (%)b 
1 0-120 92 85 
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2 120-180 94 83 
3 180-240 93 81 
4 240-300 94 80 
5 300-360 94 75 
6 360-420 94 73 
a) Isolated yield after chromatography. b) Enantiomeric excess was determined by HPLC on chiral stationary phase 
 
As reported in Table the flow system was stable for seven hours, producing chiral amine 11b in 
excellent yield (always higher than 90%) and good e.e.. The stereoselectivity of the process slightly 
decreased with time, probably because of a very slow, but constant, partial degradation of the 
imidazolidinone ring of the catalyst.[12] 
Then, we decided to study the in-flow synthesis of a valuable compound such as 1-(m-
benzyloxyphenyl)-ethylamine 11k, precursors, among others, of rivastigmine, of the calciomimetic 
(R)-NPS 568 and of Acrylamide (S)-A, currently under study for the treatment of neuropathic pain 
(Figure 2).[13] 
By employing the packed-bed reactor P1 the continuous flow process afforded chiral amine 
11k  in 82% yield and 83% e.e. for the first three operation hours (Scheme 5). The chiral amine was 
continuously produced for other 2 hours with similar yield and enantioselectivity, while, in the 
course of the sixth hour, a process of comparable yield and a minimally decreased selectivity was 
observed (79% yield and 77% e.e).[14] 
 
Scheme 5. Continuous flow synthesis of amine 11k. 
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2 180-300 80 81 
3 300-360 79 77 
a) Isolated yield after chromatography. b) Enantiomeric excess was determined by HPLC on chiral stationary phase 
 
In conclusion, a new class of solid supported chiral Lewis bases for the catalytic reduction of 
imines with trichlorosilane was studied. Polystyrene-immobilized catalysts promoted the reaction in 
very high enantioselectivites for a wide variety of substrates, up to 97% e.e. The possibility to 
decrease the catalyst's loading down to 1 mol % and to recycle the catalyst six times was 
demonstrated. The polymer-supported catalyst of choice was used to prepare packed bed reactors for 
the synthesis of chiral amines under continuous flow conditions and applied to the preparation of an 
advanced precursor of important pharmaceutically active compounds. The combination of catalytic 
reactors with recently developed synthetic and analytical devices for the in-flow processes, will offer 
new unforeseen and readily exploitable opportunities for the automated synthesis of complex 
molecules.[15] 
 
Experimental Section 
General procedure for batch reaction 
Supported catalyst (0.02 mmol) and imine (0.1 mmol) were introduced into a vial and dissolved in 
dry CH2Cl2 (1 mL) under inert atmosphere. HSiCl3 (1 M solution in CH2Cl2, 5 equiv.) was added at 
0° C and then the reaction was stirred at room temperature for 18 hours. After this reaction time the 
supported catalyst was removed by filtration and washed with dichloromethane. The organic layer 
was treated with NaOH 10% aq. until basic pH = 9. The organic layer was collected, dried with 
Na2SO4 and concentrated under vacuum. The residue was purified by column chromatography on 
silica gel. The enantiomeric excess was determined by HPLC on chiral stationary phase. 
 
General procedure for continuous flow reaction 
A 0.05 M mixture of imine (0.1 mmol) and HSiCl3 (5 equiv.) in dry CH2Cl2 (2 mL) was charged into 
a 2.5 mL SGE gas tight syringe and fixed on a syringe pump. The syringe was connected to the 
packed bed reactor and flushed at the indicated flow rate. The reactor was then washed with pure 
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CH2Cl2 at the same flow rate. The outcome of the reactor was collected into a flask containing NaOH 
10% solution. After phase separation and concentration the product was isolated. At predetermined 
intervals of time the product was collected and analyzed. The yield was determined by 
chromatography  and the ee was determined on HPLC on chiral stationary phase. 
 
Supporting Information. Synthesis of catalysts, substrates, general procedures for batch and flow 
synthesis, products characterization, NMR spectra and HPLC traces.  
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Graphical Abstract  
A new recyclable, polystyrene supported catalyst of wide general applicability, promoted the 
trichlorosilane-mediated imine reduction with a remarkable activity, even with a loading as low as 1 
mol %; excellent stereocontrol ability, up to 98% e.e. was observed, in most cases ranging between 
90-95% e.e. By exploiting packed bed chiral organocatalytic reactors, the in-flow stereoselective 
synthesis of chiral amines, precursors of valuable APIs, was accomplished in satisfactory yields and 
enantioselectivities. 
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